Artera Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Artera Inc. - overview
Established
2021
Location
Los Altos, CA, US
Primary Industry
Healthcare
About
Based in California, US, and founded in 2021, Artera Inc. operates as a healthcare company which is a medical company that develops and offers artificial intelligence-based predictive and prognostic cancer tests. In March 2023, Artera Inc. raised USD 90 million in venture funding from Breyer Capital, Coatue Management, FactoryHQ, Johnson & Johnson Innovation, etc.
As of March 2023, Andre Esteva is the Chief Executive Officer (CEO) of the company. Artera Inc. is a medical company that is developing AI tests to personalize cancer treatment for patients. The company's test offers risk classification and therapeutic benefit prediction, including the first-ever predictive test for localized prostate cancer.
In addition, the firm is a creator of prognostic and predictive AI biomarkers for immune system control, and the development of the company can predict patient outcomes and personalize treatment in localized prostate cancer, allowing patients to receive hormone therapy. The company plans to use the March 2023 funding to invest in the development of tests to support therapy and to expand its business reach.
Current Investors
Walden Catalyst, Johnson & Johnson Innovation, Coatue Management
Primary Industry
Healthcare
Sub Industries
Healthcare, Diagnostic Equipment
Website
www.artera.ai
Verticals
Cloud Computing, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.